Bank Of America Corp Infinity Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.14 - $0.24 $6,212 - $10,650	-44,378 Reduced 98.32%	758 $0
Q1 2023 May 12, 2023	BUY	$0.16 - $0.74 $3,882 - $17,955	24,264 Added 116.25%	45,136 $7,000
Q4 2022 Feb 10, 2023	SELL	$0.46 - $1.21 $28,187 - $74,146	-61,278 Reduced 74.59%	20,872 $11,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $13,458 - $38,778	-22,811 Reduced 21.73%	82,150 $98,000
Q2 2022 Aug 12, 2022	BUY	$0.49 - $1.2 $48,857 - $119,650	99,709 Added 1898.5%	104,961 $66,000
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $15,591 - $44,023	-18,343 Reduced 77.74%	5,252 $6,000
Q4 2021 Feb 08, 2022	BUY	$1.86 - $3.36 $28,117 - $50,793	15,117 Added 178.31%	23,595 $53,000
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $25,049 - $62,953	-16,480 Reduced 66.03%	8,478 $29,000
Q2 2021 Sep 13, 2021	BUY	$2.66 - $3.47 $66,388 - $86,604	24,958 New	24,958 $75,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.